Validating novel diagnostic assays for tuberculosis in the context of existing tools.

Simple item page
dc.contributor.affiliationCenter for Tuberculosis and Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA 94110, USA; Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
dc.contributor.affiliationDivision of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA 94110, USA. Electronic address: andrew.kerkhoff@ucsf.edu.
dc.contributor.affiliationDivision of Tropical Medicine, Center of Infectious Diseases, University of Heidelberg, Heidelberg, Germany.
dc.contributor.affiliationTB Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
dc.contributor.affiliationUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorKerkhoff AD
dc.contributor.authorCattamanchi A
dc.contributor.authorMuyoyeta M
dc.contributor.authorDenkinger CM
dc.contributor.authorDowdy DW
dc.date.accessioned2025-05-23T11:40:56Z
dc.date.issued2021-Sep
dc.identifier.doi10.1016/S2214-109X(21)00306-5
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10349
dc.sourceThe Lancet. Global health
dc.titleValidating novel diagnostic assays for tuberculosis in the context of existing tools.

Files

Collections

Published